EP Patent

EP0223403A2 — Piperidine derivative, its preparation, and its use as medicament

Assigned to Beecham Group PLC · Expires 1987-05-27 · 39y expired

What this patent protects

The invention provides crystalline paroxetine hydrochloride hemihydrate, processes for its preparation, compositions containing the same and its therapeutic use.

USPTO Abstract

The invention provides crystalline paroxetine hydrochloride hemihydrate, processes for its preparation, compositions containing the same and its therapeutic use.

Drugs covered by this patent

Patent Metadata

Patent number
EP0223403A2
Jurisdiction
EP
Classification
—
Expires
1987-05-27
Drug substance claim
No
Drug product claim
No
Assignee
Beecham Group PLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.